{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:24:48Z","timestamp":1753885488471},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,2,17]],"date-time":"2008-02-17T00:00:00Z","timestamp":1203206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sarcoidosis is a systemic granulomatous disease that is triggered by an autoimmune process, and is now a well recognized but uncommon complication of antiviral therapy for Hepatitis C virus (HCV) infection, likely related to its immunomodulatory effects. The clinical presentation of HCV related sarcoidosis is as varied as systemic sarcoidosis, but ocular presentation alone has not been reported previously. We present a 23 year\u2010old female who developed visual disturbances due to ocular sarcoidosis during the course of antiviral therapy for chronic HCV infection. Our case presentation is then followed by a review of the literature on the topic. We aim to stress the importance of screening for eye problems in following HCV patients undergoing antiviral therapy, and raise clinicians\u2019 awareness of sarcoidosis as a possible cause for eye problems even in the absence of respiratory complaints.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2007.01625.x","type":"journal-article","created":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T01:49:32Z","timestamp":1203299372000},"page":"207-210","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C"],"prefix":"10.1111","volume":"38","author":[{"given":"K. K. L.","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dinihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Freiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zekry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,17]]},"reference":[{"key":"e_1_2_4_2_2","unstructured":"WHO press release.Hepatitis C.: 170 Million Infected Worldwide and Still no Vaccine.Press Release WHO\/36 1May 1998"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36518"},{"issue":"1","key":"e_1_2_4_6_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/112067210601600128","article-title":"Conjunctival deposits as the first sign of systemic sarcoidosis in a pediatric patient","volume":"16","author":"Caca I","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(05)80273-5"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.19"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80357-7"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021759120428"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00746.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00745.x"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(03)00078-5"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000157577.69729.e6"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.376"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200209000-00018"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000157764.44292.aa"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.2177\/jsci.26.336"},{"key":"e_1_2_4_19_2","first-page":"264","article-title":"[Systemic sarcoidosis during interferon\u2010\u03b1 therapy for chronic hepatitis C virus infection] (abstract)","volume":"24","author":"Cacoub P","year":"2000","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"e_1_2_4_20_2","article-title":"Blurred vision: cause? Retinopathy secondary to interferon treatment","volume":"55","author":"Bowen DW","year":"2006","journal-title":"Gut"},{"issue":"2","key":"e_1_2_4_21_2","first-page":"309","article-title":"Retinal complications during interferon therapy for chronic hepatitis C","volume":"91","author":"Kawano T","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270533"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00105.x"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350200088"},{"key":"e_1_2_4_25_2","first-page":"32","article-title":"Cutaneous sarcoidosis, Sjogren syndrome and autommune thyroiditis associated with hepatitis C virus infection","volume":"123","author":"Belgodere X","year":"1995","journal-title":"Eur J Dermatol"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i1.150"},{"key":"e_1_2_4_27_2","first-page":"594","article-title":"A case of sarcoidosis exacerbated after acute hepatitis C (abstract)","volume":"40","author":"Nagaham H","year":"2002","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s535-002-8133-3"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-0963.2001.04570.x"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2007.01625.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2007.01625.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:48:31Z","timestamp":1697323711000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2007.01625.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,17]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1445-5994.2007.01625.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2007.01625.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,17]]},"assertion":[{"value":"2008-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}